Eikon Therapeutics uses high-resolution microscopes that view cell activity in real time, with an eye to using that data to accelerate drug discovery.
Category: alexknappblog
InnovationRx: Treating ‘Undruggable’ Diseases; Plus, Omicron In Europe
InnovationRx is your weekly digest of healthcare news. Sign up!
New Data Confirms Covid Antiviral Drug 89% Effective At Preventing Hospitalizations And Death, Pfizer Says
The pharmaceutical giant says new data from its Phase 2/3 studies a previous analysis of the drug’s effectiveness.
FDA Greenlights Booster Shots Of Pfizer/BioNTech’s Covid Vaccine For 16 And 17-Year-Olds
Pfizer and BioNTech will also apply to the FDA to expand the approval of their companies’ vaccine to include the third dose.
This Biotech Company Raised $40 Million To Develop Treatments For ‘Undruggable’ Diseases
Totus Medicines’ has come out of stealth with a technology that could enable it to treat cancers with known targets but no specific drugs—and it’s going into clinical trials next year.
2022 Franklin Institute Awards Announced: Covid Vaccine CEOs Honored For Business Leadership
The CEOs of Pfizer, Moderna and Johnson & Johnson were honored with the Bower Award for their work in developing vaccines to combat the pandemic.
Rally Health Founder’s New Startup Is Focused On Artificial Intelligence
Grant Verstandig’s newest company, ZephyrAI, aims to use AI for better drug discovery and personalized health.
Pfizer Is Submitting Its Covid Antiviral To The FDA For Emergency Authorization
If authorized, the pill would be the first of its kind to treat Covid.
Pfizer Signs Deal To Share Its Covid Antiviral Pill With Low Income Nations
The pharmaceutical giant and its development partner Ridgeback Therapeutics signed a licensing deal that will boost access to their new drug.
Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical Study
The pharmaceutical giant will submit the data to the FDA to continue its application for emergency use authorization.
